CTT awarded Cockpit Humidification for Irkut`s MC-21

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CTT awarded Cockpit Humidification for Irkut`s MC-21

NYKÖPING, Sweden, July 10th, 2014 CTT SYSTEMS (“CTT”), the market leader for non -condensation systems in commercial aircraft structures and the world’s leading provider of humidification products for cockpit, crew rest and passenger cabin areas, today announces that JSC PDC Teploobmennik selected CTT for Cockpit Humidification of the Irkut`s MC-21 Aircraft Family. JSC PDC Teploobmennik, based in Nizhny Novgorod Russia, is tier-1 supplier for the Integrated Air Management system on the MC-21 aircraft. The CTT Flight Deck Humidifier will be base line equipment (i.e. standard equipment on all MC-21 aircraft). The MC-21 is in development phase, with the first test flight scheduled for 2015 and entry into service in 2017, will be produced by Irkut and Yakovlev Design Bureau of the United Aircraft Corporation (UAC) group. The MC-21 will encompass three twin-engine short- and mid-range aircraft versions with 150 to 210 passengers. The aircraft program has total commitments of 276 aircraft including 175 firm orders. “We are pleased with the decision to standard equip the MC-21 with our cockpit humidifiers, comments Torbjörn Johansson CEO of CTT SYSTEMS.” About Teploobmennik JSC PDC “Teploobmennik” is one of the leading Russian companies for aerospace industry specializes in design, development and manufacture of Aerospace Environmental Control Systems (ECS) and equipment. Using its unique competence and more than 70 years of experience, JSC PDC “Teploobmennik” was selected as a tier-1 supplier for the Integrated Air Management System and Wing Anti-Ice System on the MC-21 aircraft. Also visit: www.teploobmennik.ru About Irkut and MC-21 JSC “IRKUT Corporation” is one of the leading Russian aircraft manufacturer, and is a subsidiary of UAC (“United Aircraft Corporation” JSC), a supplier in a number of civil and military programs, as well as producing components for Airbus aircraft. The МС‑21; "Магистральный Самолёт 21 века" - "Magistralny Samolyot 21 veka" - "Airliner of the 21st Century"); is developed in partnership with global manufacturers of aircraft systems and components; targets a new generation passenger aircraft in the 150-210 seat segment. Read more… http://www.uacrussia.ru/en/models/civil/ms-21/ About CTT SYSTEMS (Publ.) Cair™ is focused on the passengers’ health and comfort by providing humidification of the extremely dry aircraft cabins without causing condensation. Cair™ gives a pleasant relative humidity of around 20%, compared to 3-5% without, for the passengers, thereby reducing dry air related problems (e.g. fatigue, jet-lag, red eyes, dry skin, spread of virus diseases). The Cair™ system is based on evaporative cooling technology and uses a method that effectively precludes the transfer of bacteria within the aircraft. The dual-purpose system increases humidity for greater comfort and incorporates the Zonal Drying™ System to counter condensation problems. CTT’s Zonal Drying™ System has been selected as basic equipment for the new B787 “Dreamliner” and CTT’s humidifiers are options in crew rest compartments and on the flight deck. The A380 offers CTT’s humidifiers as option in crew rest compartments. CTT will also supply the Zonal Drying™ system and the Cair™ system for the A350 aircraft, as options. CTT is the de-facto standard for non-condensation systems preventing condensate water to accumulate (read: excess weight) in commercial aircraft structures and the dominating provider of humidification products for cockpit, crew rest and cabin areas. CTTs products Zonal Drying™, Cair™, Flight Deck and Crew Humidifiers are standard or optional equipment on the Boeing 787, Airbus A350 and the A380. About CTT products Zonal Drying™ - non-condensation – Basic equipment for B787 and BFE for B737 CAIR™ - Premium Cabin Humidification – SFE on A350 and retrofit products for B777, A330 and A380 Crew Rests Humidification – Basic Equipment on the 787-CRC SFE and SFE on A380/A350 Some dry facts on long-haul traveling · The only humidity contribution in an aircraft is from passengers and crew · The cabin with less seat density and with the highest cost per seat is ironically the one with the lowest humidity! · The Relative Humidity (RH) is lower than 5% in First Class and 7-10% in Business Class · Crew Rest Compartments typically encompass a RH well below 5 % · The extremely dry air in the cabin cause human discomfort, such as cold and allergy symptoms, sleeping difficulties, dry skin and eyes and general fatigue. · Medical studies prove that even a slight RH-increase from extremely low levels, is beneficial to health, as the increased humidity improve tear film stability and nasal patency. It also reduces headaches and ocular, nasal and dermal dryness symptoms. CAIR™ - Cabin Humidification a landmark in premium traveling · Airlines no longer are limited by the extreme-dry-air-law-of-nature setting the statutory condition for their in-sky offering · Passenger will benefit more from all cabin interior investments such as seating – feeling more at ease and pleased · Passengers and Crew gain from improvements in wellbeing, rest and over-all experience · Flavors will be more accessible in the palate and healthier too, with no need to over doze anything such as salt or sugar · Increased Humidity is an ‘enabling ingredient’ for more varieties, new species, flavors and combinations in the sky Zonal Drying™ - by eliminating fuselage condensation both operational and maintenance costs will be lowered through: · lowered fuel consumption (i.e. lower aircraft weight - 200-300 kg on A320/B737 due to elimination of accumulated water), · improved operational reliability (i.e. less corrective maintenance), · consistent insulation performance (i.e. water reduces insulation performance), · reduced fuel burn also has a positive impact on the environment and finally · Condensation issues are increasingly important to airlines as fuel stands for some 40 % of OPEX. This information is disclosed by CTT Systems AB in accordance with the Swedish Securities Markets Act, the Swedish Financial Instruments Trading Act, or the requirements stated in the listing agreements. The information was submitted for publication on 10th of July 2014 at 09:50 (CET). For additional information: Torbjörn Johansson, President, CTT Systems AB. Tel. +46-155-205901 alt. mobile. +46-70-665 24 46, or E-mail: torbjorn.johansson@ctt.se Also visit: www.ctt.se CTTs products Zonal Drying ™, Cair ™, Flight Deck and Crew Humidifier are standard or optional equipment on Boeing B787, Airbus A350 and A380. CTT has today more than 500 systems installed in more than 30 airlines worldwide. CTT has now 21 years of operating experience on the Zonal Drying ™ system plus 15 years on Cair ™ and Crew Humidifier systems. IATAs report on fuel-saving measures is now including Zonal Drying ™ as one of the few available fuel-saving systems for retrofitting.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading